Unknown

Dataset Information

0

Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice.


ABSTRACT:

Rationale

Chronic obstructive pulmonary disease (COPD) is a widespread disease, with no curative therapies available. Recent findings suggest a key role of NO and sGC-cGMP signaling for the pathogenesis of the disease. Previous data suggest a downregulation/inactivation of the cGMP producing soluble guanylate cyclase, and sGC stimulation prevented cigarette smoke-induced emphysema and pulmonary hypertension (PH) in mice. We thus aimed to investigate if the inhibition of the cGMP degrading phosphodiesterase (PDE)5 has similar effects. Results were compared to the effects of a PDE 4 inhibitor (cAMP elevating) and a combination of both.

Methods

C57BL6/J mice were chronically exposed to cigarette smoke and in parallel either treated with Tadalafil (PDE5 inhibitor), Piclamilast (PDE4 inhibitor) or both. Functional measurements (lung compliance, hemodynamics) and structural investigations (alveolar and vascular morphometry) as well as the heart ratio were determined after 6 months of tobacco smoke exposure. In addition, the number of alveolar macrophages in the respective lungs was counted.

Results

Preventive treatment with Tadalafil, Piclamilast or a combination of both almost completely prevented the development of emphysema, the increase in lung compliance, tidal volume, structural remodeling of the lung vasculature, right ventricular systolic pressure, and right ventricular hypertrophy induced by cigarette smoke exposure. Single, but not combination treatment prevented or reduced smoke-induced increase in alveolar macrophages.

Conclusion

Cigarette smoke-induced emphysema and PH could be prevented by inhibition of the phosphodiesterases 4 and 5 in mice.

SUBMITTER: Seimetz M 

PROVIDER: S-EPMC4461257 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice.

Seimetz Michael M   Parajuli Nirmal N   Pichl Alexandra A   Bednorz Mariola M   Ghofrani Hossein Ardeschir HA   Schermuly Ralph Theo RT   Seeger Werner W   Grimminger Friedrich F   Weissmann Norbert N  

PloS one 20150609 6


<h4>Rationale</h4>Chronic obstructive pulmonary disease (COPD) is a widespread disease, with no curative therapies available. Recent findings suggest a key role of NO and sGC-cGMP signaling for the pathogenesis of the disease. Previous data suggest a downregulation/inactivation of the cGMP producing soluble guanylate cyclase, and sGC stimulation prevented cigarette smoke-induced emphysema and pulmonary hypertension (PH) in mice. We thus aimed to investigate if the inhibition of the cGMP degradin  ...[more]

Similar Datasets

| S-EPMC4830240 | biostudies-literature
| S-EPMC10118454 | biostudies-literature
2020-03-01 | GSE112287 | GEO
| S-EPMC2742758 | biostudies-literature
| S-EPMC4742374 | biostudies-literature
| S-EPMC5652808 | biostudies-literature
| S-EPMC6629245 | biostudies-other
| S-EPMC524225 | biostudies-literature
| S-EPMC4050371 | biostudies-literature
| S-EPMC5625220 | biostudies-literature